Neoadjuvant endocrine therapy in locally advanced estrogen or progesterone receptor-positive breast cancer: determining the optimal endocrine agent and treatment duration in postmenopausal women—a literature review and proposed guidelines

Neoadjuvant endocrine therapy in locally advanced estrogen or progesterone receptor-positive breast cancer: determining the optimal endocrine agent and treatment duration in postmenopausal women—a literature review and proposed guidelines

Abstract Introduction For patients with locally advanced estrogen receptor or progesterone receptor-positive breast cancer, neoadjuvant endocrine therapy (NET) facilitates down-staging of the tumor and increased rates of breast-conserving surgery. However, NET remains under-utilized, and there are v...

Full description

Bibliographic Details
Main Authors: Lauren I. Madigan, Phuong Dinh, J. Dinny Graham
Format: Article
Language:English
Published: BMC 2020-07-01
Series:Breast Cancer Research
Subjects:
Neoadjuvant endocrine therapy
Selective estrogen receptor modulators
Aromatase inhibitors
Online Access:http://link.springer.com/article/10.1186/s13058-020-01314-6

Internet

http://link.springer.com/article/10.1186/s13058-020-01314-6

Similar Items